Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial

Completeness and accuracy of national cancer and death registration for outcome ascertainment in trials—an ovarian cancer exemplar

(2021) Jatinderpal K. Kalsi et al.   Trials

UKCTOCS update: applying insights of delayed effects in cancer screening trials to the long-term follow-up mortality analysis

(2021) Matthew Burnell et al.   Trials

Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial

(2020) Harry J. de Koning et al.   NEW ENGLAND JOURNAL OF MEDICINE

Comparison of longitudinal CA125 algorithms as a first line screen for ovarian cancer in the general population

(2018) Oleg Blyuss et al.   CLINICAL CANCER RESEARCH

Survival of Women With Type I and II Epithelial Ovarian Cancer Detected by Ultrasound Screening

(2018) John R. van Nagell et al.   OBSTETRICS AND GYNECOLOGY

Evidence of Stage Shift in Women Diagnosed With Ovarian Cancer During Phase II of the United Kingdom Familial Ovarian Cancer Screening Study

(2017) Adam N. Rosenthal et al.   JOURNAL OF CLINICAL ONCOLOGY

The new WHO classification of ovarian, fallopian tube, and primary peritoneal cancer and its clinical implications

(2016) Ivo Meinhold-Heerlein et al.   ARCHIVES OF GYNECOLOGY AND OBSTETRICS

Extended mortality results for ovarian cancer screening in the PLCO trial with median 15 years follow-up

(2016) Paul F. Pinsky et al.   GYNECOLOGIC ONCOLOGY

Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial

(2016) Ian J Jacobs et al.   LANCET

Risk Algorithm Using Serial Biomarker Measurements Doubles the Number of Screen-Detected Cancers Compared With a Single-Threshold Rule in the United Kingdom Collaborative Trial of Ovarian Cancer Screening

(2015) Usha Menon et al.   JOURNAL OF CLINICAL ONCOLOGY

Insights from the Breast Cancer Screening Trials: How Screening Affects the Natural History of Breast Cancer and Implications for Evaluating Service Screening Programs

(2014) László Tabár et al.   Breast Journal

Prostate-Cancer Mortality at 11 Years of Follow-up

(2012) Fritz H. Schröder et al.   NEW ENGLAND JOURNAL OF MEDICINE

Colorectal-Cancer Incidence and Mortality with Screening Flexible Sigmoidoscopy

(2012) Robert E. Schoen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effect of Screening on Ovarian Cancer Mortality

(2011) Saundra S. Buys   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)

(2009) Usha Menon et al.   LANCET ONCOLOGY

The Preclinical Natural History of Serous Ovarian Cancer: Defining the Target for Early Detection

(2009) Patrick O. Brown et al.   PLOS MEDICINE

A randomized study of screening for ovarian cancer: a multicenter study in Japan

(2007) H. KOBAYASHI et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER